SK hynix Says Oversupply Risk Limited, Plans Gradual Capacity Expansion

Finance|
|
By Kim Yoon-soo
||
A view of SK hynix's Icheon plant. Photo=SK hynix - Seoul Economic Daily Finance News from South Korea
A view of SK hynix's Icheon plant. Photo=SK hynix

SK hynix (000660.KS) dismissed concerns about oversupply stemming from the recent race among memory companies to expand production capacity, saying "the likelihood of this leading directly to oversupply is limited."

During a conference call on the 29th to announce its second-quarter earnings this year, SK hynix said, "The capacity expansion currently under way is based on demand visibility secured through strengthened partnerships with customers." The company added, "Actual equipment investment will proceed in stages, taking into account customer demand visibility and investment efficiency."

SK hynix also said its capacity expansion "will be carried out flexibly," conveying its policy of controlling the pace of supply.

Companies in this story

Original reporting by Kim Yoon-soo for Seoul Economic Daily.

AI-translated from Korean. Quotes from foreign sources are based on Korean-language reports and may not reflect exact original wording.

Watch · Seoul Economic Daily

More →
2:32

AI KEY

Preview
Korean Corporate Intelligence HubKOSPI · KOSDAQ · 12 sectors

A live, cap-weighted view of every KOSPI and KOSDAQ sector, with same-day Korean reporting distilled by company — built for foreign investors, correspondents and analysts who need to scan Korea before the next session.

Korea Company Atlas

Preview
Market Ontology · The Feedback LoopKFTC 2025 · 92 groups · 121,954 articles

An English ontology of the Korean market — how companies, the media, the government and the National Assembly move each other in a loop. Korea's named controlling persons and designated business groups are a mechanism, not a risk to be priced blind.

SIGNAL

Pre-register
English Edition · Capital MarketsM&A · IPO · PE · Fund Flows

Pre-register for SIGNAL English Edition — a premium subscription bringing Korean capital markets coverage (M&A, IPOs, private equity, fund flows) to global institutional investors. First access to the 50% introductory rate.